More peptides were identified from the lung adenocarcinoma cell lines, PC9 and H1975, compared with the EGFR-mutant tumor, NCI-RA007, and the melanoma patient–derived cell lines. This evidence concerns the gene EGFR and lung adenocarcinoma.